Mei

TELLURIDE X-PRO CLAIMS THIRD-PLACE PODIUM FINISH IN 2023 REBELLE RALLY

Retrieved on: 
Saturday, October 28, 2023
EVP, NBA, Photography, PHEV, Gasoline, Multimedia, SUV, Mei, HEV, K5, Road, Kia, Telluride, Kia Sportage

"We couldn't be prouder of our team's exceptional performance this year in the Rebelle Rally," said Steven Center, COO & EVP, Kia America.

Key Points: 
  • "We couldn't be prouder of our team's exceptional performance this year in the Rebelle Rally," said Steven Center, COO & EVP, Kia America.
  • Outfitted by Baja Forged, the modified Telluride X-Pro finished the rally without experiencing any major issues, and never once did the team need to change a tire.
  • "The Telluride X-Pro is the most capable vehicle I've driven in the Rebelle Rally and it delivered exceptionally well," said Mei.
  • In 2022, a modified 2023 Sportage competed and in 2021, two modified 2022 Sorento PHEVs earned second-and third-place podium spots.

MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Monday, August 2, 2021
Financial markets, Finance, Money, Corporate finance, Economy of New York City, NASDAQ, Option, Stock

The stock options were granted as a material inducement to each new employee accepting employment with MEI in accordance with Nasdaq Listing Rule 5635(c)(4).

Key Points: 
  • The stock options were granted as a material inducement to each new employee accepting employment with MEI in accordance with Nasdaq Listing Rule 5635(c)(4).
  • The stock options have a $2.70 exercise price per share, which is equal to the closing price of the Company's common stock on the grant date.
  • The options were granted pursuant to the MEI Pharma, Inc. 2021 Inducement Grant Equity Compensation Plan, and have terms and conditions consistent with the MEI Pharma, Inc.
  • MEI Pharma, Inc. (Nasdaq: MEIP) is a late-stage pharmaceutical company focused on developing potential new therapies for cancer.

Methode Electronics’ Board Approves Dividend Increase

Retrieved on: 
Thursday, June 17, 2021
Electronics manufacturing, Methode Electronics, Dividend, Mei, New York Stock Exchange, Companies, Corporate finance

CHICAGO, June 17, 2021 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, LED lighting system, and power distribution applications, announced today that its board of directors has declared a quarterly dividend of $0.14 per share to be paid on July 30, 2021 to common stockholders of record at the close of business on July 16, 2021.

Key Points: 
  • CHICAGO, June 17, 2021 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, LED lighting system, and power distribution applications, announced today that its board of directors has declared a quarterly dividend of $0.14 per share to be paid on July 30, 2021 to common stockholders of record at the close of business on July 16, 2021.
  • The amount represents a 27 percent increase from the previously declared dividend and is further evidence of the companys commitment to a balanced capital allocation strategy.
  • Methode Electronics, Inc. (NYSE: MEI) is a leading global supplier of custom-engineered solutions with sales, engineering and manufacturing locations in North America, Europe, Middle East, and Asia.
  • Our business is managed on a segment basis, with those segments being Automotive, Industrial, Interface and Medical.

MEI Pharma to Host Investor and Analyst Video Webcast Event Following 2021 ASCO Annual Meeting

Retrieved on: 
Friday, June 4, 2021
Video game characters, Fictional characters, Mei, Fiction

SAN DIEGO, June 4, 2021 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapiesfor cancer, today announcedit will host an investor and analyst video webcast event onThursday, June 10, 2021at12:00 PM ETfollowing the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting.

Key Points: 
  • SAN DIEGO, June 4, 2021 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapiesfor cancer, today announcedit will host an investor and analyst video webcast event onThursday, June 10, 2021at12:00 PM ETfollowing the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting.
  • The event will include additional zandelisib data as well as an overview and update of MEI's business.
  • You can access the live video webcast under the investor relations section of MEI's website on the "Events and Presentation" page at: www.meipharma.com .A replay of the video webcast will be archived for at least 30 days after the conclusion of the live event.
  • MEI Pharma, Inc. (Nasdaq: MEIP) is a late-stage pharmaceutical company focused on developing potential new therapies for cancer.

Methode Electronics to Present at the Stifel 2021 Virtual Cross Sector Insight Conference

Retrieved on: 
Wednesday, June 2, 2021
Electronics manufacturing, Methode Electronics, Stifel, Mei, New York Stock Exchange, Service companies, Companies, Finance

CHICAGO, June 02, 2021 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, LED lighting system, and power distribution applications, will present at the Stifel 2021 Virtual Cross Sector Insight Conference on Wednesday, June 9 at 9:20 a.m. EDT.

Key Points: 
  • CHICAGO, June 02, 2021 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, LED lighting system, and power distribution applications, will present at the Stifel 2021 Virtual Cross Sector Insight Conference on Wednesday, June 9 at 9:20 a.m. EDT.
  • A simultaneous webcast can be accessed through the companys website, www.methode.com, by selecting the Investors page.
  • Methode Electronics, Inc. (NYSE: MEI) is a leading global supplier of custom-engineered solutions with sales, engineering and manufacturing locations in North America, Europe, Middle East, and Asia.
  • Our business is managed on a segment basis, with those segments being Automotive, Industrial, Interface and Medical.

MEI Pharma Announces the Retirement of Chief Medical Officer Robert Mass and Promotion of Richard Ghalie to Chief Medical Officer

Retrieved on: 
Friday, April 30, 2021
Pharma, Mei

b'SAN DIEGO, April 30, 2021 /PRNewswire/ --MEI Pharma, Inc. (NASDAQ: MEIP) ("MEI"), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the retirement of Robert Mass, M.D., MEI\'s chief medical officer.

Key Points: 
  • b'SAN DIEGO, April 30, 2021 /PRNewswire/ --MEI Pharma, Inc. (NASDAQ: MEIP) ("MEI"), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the retirement of Robert Mass, M.D., MEI\'s chief medical officer.
  • I want to thank Bob for his dedication to MEI and his friendship over these past 10 years.
  • We wish him the very best in his retirement and look forward to continued interaction through his advisory role," saidDaniel P. Gold, Ph.D., president and chief executive officer of MEI Pharma.
  • Mass commented, "Working with Dan and the entire MEI team over the past decade has been deeply rewarding and this is an ideal time for my transition.

MEI Awards: the "Global Boutique Briefing" is coming together with CIIF

Retrieved on: 
Wednesday, September 16, 2020
Mei

MEI Awards is also gradually developing from a simple selecting award to an innovative energized platform in the last 10 years.

Key Points: 
  • MEI Awards is also gradually developing from a simple selecting award to an innovative energized platform in the last 10 years.
  • The diversified waysthat MEI Awards presents and promotes high-quality Chinese productsofferglobal buyers a great chance to find the ideal products easily.
  • MEI Awards is always cooperating with CIIF positively since it come out.
  • This year, MEI Awards also organizes its "Global Boutique Briefing" with CIIF and will bring the newest and smartest Chinese products to the global buyers.

MEI Awards: Leads Made-in-China products develop beyond imagination

Retrieved on: 
Tuesday, August 18, 2020
Articles, Design, Innovation, Product management, Mei

In order to break this stereotype, Made-in-China.com, as the connection of Chinese suppliers and global buyers, launched the original MEI Awards in 2011.

Key Points: 
  • In order to break this stereotype, Made-in-China.com, as the connection of Chinese suppliers and global buyers, launched the original MEI Awards in 2011.
  • These selected products are able to represent the top level of Chinese products and would be showed both online and offline around the world.
  • "We shall keep assisting with enterprises in improving designing and ability of innovation", said by the director of MEI Awards.
  • MEI Awards is keeping forward with Chinese enterprises.Consumers canwait and see the top quality and brightest Chinese products.

MEI Rigging & Crating Expands into Southeast with the Acquisition of Adams Machinery Movers

Retrieved on: 
Thursday, May 28, 2020
Metalworkers, Millwright, Woodworkers, MSC ADAMS, Yang Yang, Mover, Ellenwood, Mei, Fly system, Entertainment, Human activities, Crafts

ELLENWOOD, Ga., May 28, 2020 /PRNewswire/ --MEI Rigging & Crating, LLC ("MEI"), a leading provider of machinery moving, millwrighting, installation, crating and export packing services, announced that it has acquired Adams Machinery Movers, Inc. ("Adams").

Key Points: 
  • ELLENWOOD, Ga., May 28, 2020 /PRNewswire/ --MEI Rigging & Crating, LLC ("MEI"), a leading provider of machinery moving, millwrighting, installation, crating and export packing services, announced that it has acquired Adams Machinery Movers, Inc. ("Adams").
  • Buddy and Tony Adams founded Adams in 1990 and have grown the business into one of Atlanta's premier specialty rigging outfits.
  • "We at MEI are proud to announce our acquisition of Adams Machinery Movers.
  • For media inquiries and relevant opportunities, please contact [email protected]
    View original content to download multimedia: http://www.prnewswire.com/news-releases/mei-rigging--crating-expands-int...
    SOURCE MEI Rigging & Crating, LLC

MEI Pharma to Host Investor and Analyst Video Webcast Following ASCO20 Virtual Scientific Program

Retrieved on: 
Tuesday, May 26, 2020
Video game characters, Fictional characters, Fiction, Pharma, Mei

SAN DIEGO, May 26, 2020 /PRNewswire/ --MEI Pharma, Inc. (NASDAQ: MEIP) ("MEI"), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that it will host an investor and analyst video webcast event on Tuesday, June 2nd, 2020 at 8:00 AM ET following the ASCO20 Virtual Scientific Program.

Key Points: 
  • SAN DIEGO, May 26, 2020 /PRNewswire/ --MEI Pharma, Inc. (NASDAQ: MEIP) ("MEI"), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that it will host an investor and analyst video webcast event on Tuesday, June 2nd, 2020 at 8:00 AM ET following the ASCO20 Virtual Scientific Program.
  • You can access the live video webcast under the investor relations section of MEI's website on the "Events and Presentation" page at: www.meipharma.com .A replay of the video webcast will be archived for at least 30 days after the conclusion of the live event.
  • MEI Pharma, Inc. (Nasdaq: MEIP) is a late-stage pharmaceutical company focused on developing potential new therapies for cancer.
  • We do not intend to update any of these factors or to publicly announce the results of any revisions to these forward-looking statements.